Updated:
Coremix Capital
Founded in 2013 in Vancouver, Washington, Coremix Capital is the investment vehicle for entrepreneurs Marty Rifkin and Kate Jones after their 2012 exit of...
Coremix Capital
Founded in 2013 in Vancouver, Washington, Coremix Capital is the investment vehicle for entrepreneurs Marty Rifkin and Kate Jones after their 2012 exit of Avid Health to Church & Dwight. The duo built that business over 16 years, starting with a probiotic line in 1996 and eventually inventing the mass-market gummy vitamin category with the Lil Critters and VitaFusion brands. The office reflects that lifecycle: it was created to manage multi-generational wealth generated entirely from consumer health products. Coremix deploys proprietary capital across a deliberately broad mix — private equity, private credit, direct co-investments, SPVs, and commercial real estate — with a preference for growth-stage operating companies. The firm has confirmed investments in digital health, fintech, healthcare services, agri-food, industrial tech, media, gaming, edtech, and space tech, and it concentrates its geographic footprint in North America. Frequent co-investor Rogue Venture Partners appears alongside Coremix in several growth-stage rounds. The office also holds a portfolio of directly owned Vancouver commercial assets, including Campus Drive Business Park and manufacturing spaces, and runs its property operations through Pac1 Property Management. Team size and total deployment are not publicly disclosed. The office lists founders Rifkin and Jones plus partner Rick Falconer and designated broker Jordan Farley as key operators. The firm has not publicly reported a fund close or new platform launch in the last 24 months. Philanthropic activity is channeled through the KMR Group Foundation, which Jones leads as president, with a mandate centered on child health and well-being. Coremix’s structural distinction is its self-reliant, balance-sheet model built by operating founders. There is no outside LP capital, no fund cycle, and no external redemption pressure — only the post-exit liquidity of two vitamin-industry executives who reinvest directly into companies they judge by the same product-innovation lens they applied at Avid Health.
General information
Firm type
Single Family Office
Year founded
2013
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Vancouver
Corporate office
Vancouver, WA, United States
Principals
Marty Rifkin
Founder
Kate Jones
Founder
Altss tracks 2 additional named team members for this firm — including direct investment leads, IR, and operating principals not listed on the public website.
Book a demoSector focus
Frequently asked questions
Who runs investment decisions at Coremix Capital?
Founders Marty Rifkin and Kate Jones lead the firm, with partner Rick Falconer involved in operations. The office is deliberately lean, with no publicly named CIO or separate investment committee; decisions appear to rest with the founder group.
Where does the underlying wealth come from?
Coremix is funded entirely by the proceeds from Avid Health, the gummy-vitamin company Rifkin and Jones built starting in 1996 and sold to Church & Dwight in 2012 for approximately $650 million. The exit generated the multi-generational capital the office deploys today.
How does Coremix source proprietary deal flow?
The firm leverages the founders’ own entrepreneurial networks rather than relying on institutional intermediaries. Rifkin’s background as a professional musician in Bruce Springsteen’s Sessions Band and the founders’ deep ties in consumer health and Northwest manufacturing create informal sourcing channels.
Is Coremix structured as a single family office or does it operate more like a venture firm?
Coremix is a single-family office that invests directly from its own balance sheet. It does not manage third-party capital, charge management fees, or operate closed-end funds with mandated return windows, which distinguishes it structurally from a venture capital firm.
Does Coremix participate in fund commitments or only direct deals?
Coremix is primarily a direct investor, deploying capital through direct co-investments, SPVs, private credit, and real estate. There is no public record of Coremix participating as a limited partner in external venture or private equity funds.
What investment stages does Coremix typically target?
Coremix targets growth-stage, buyout, and venture investments, with a confirmed preference for operating companies that already have product-market fit. The firm’s capital products include flexible equity and subordinated debt, suggesting it can structure around both control and minority positions.
Does Coremix maintain philanthropic structures, and how are they separated?
The KMR Group Foundation, led by co-founder Kate Jones, focuses on child health and well-being. The foundation is legally distinct from the investment entity, though it is funded by the same family wealth and reflects the founders’ decades-long emphasis on children’s nutrition.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: